ALPINE IMMUNE SCIENCES, INC. — Form D

ALPINE IMMUNE SCIENCES, INC. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2021-09-29. The offering totals $91.0M, of which $91.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (30)

Showing 25 of 30 people.

NameRoleLocation
Robert Paul ConwayDirectorSeattle, WA
Mitchell Paul GoldDirectorSeattle, WA
Natasha Paul HerndayDirectorSeattle, WA
Christopher Paul PeetzDirectorSeattle, WA
Peter Paul ThompsonDirectorSeattle, WA
James Paul TopperDirectorSeattle, WA
Jay Paul VenkatesanDirectorSeattle, WA
Cui Paul XiangminDirectorSeattle, WA
Mitchell Paul GoldExecutive OfficerSeattle, WA
Zelanna Paul GoldbergExecutive OfficerSeattle, WA
Stanford Paul PengExecutive OfficerSeattle, WA
James Paul RickeyExecutive OfficerSeattle, WA
John MooreDirectorCharlottesville, VA
JOSEPH LOSCALZODirectorWALTHAM, MA
Jonathan LeffDirectorNess Ziona, L3
Paul Paul SekhriDirectorSeattle, WA
Jay James VenkatesanDirectorSeattle, WA
Mitchell James GoldDirectorSeattle, WA
Mitchell James GoldExecutive OfficerSeattle, WA
James James TopperDirectorSeattle, WA
Mark James LittonExecutive OfficerSeattle, WA
Cui James XiangminDirectorSeattle, WA
Peter James ThompsonDirectorSeattle, WA
Christopher James PeetzDirectorSeattle, WA
Robert James ConwayDirectorSeattle, WA

Other filings by this issuer (3)

FiledFormOfferingSold
2020-08-07D$82.7M$60.0M
2019-01-30D$48.7M$25.3M
2014-11-25D$40.0M$30.0M

More